Cherry Tree Wealth Management LLC Cuts Stock Position in Solventum Co. (NYSE:SOLV)

Cherry Tree Wealth Management LLC lessened its holdings in Solventum Co. (NYSE:SOLV) by 7.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,875 shares of the company’s stock after selling 150 shares during the quarter. Cherry Tree Wealth Management LLC’s holdings in Solventum were worth $124,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the business. Blue Trust Inc. boosted its holdings in shares of Solventum by 2.1% in the 4th quarter. Blue Trust Inc. now owns 7,872 shares of the company’s stock valued at $549,000 after buying an additional 161 shares during the period. MML Investors Services LLC lifted its position in Solventum by 3.2% in the 3rd quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock valued at $373,000 after purchasing an additional 168 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its position in Solventum by 4.2% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,966 shares of the company’s stock valued at $346,000 after purchasing an additional 200 shares during the last quarter. Savant Capital LLC lifted its position in Solventum by 6.3% in the 4th quarter. Savant Capital LLC now owns 3,914 shares of the company’s stock valued at $259,000 after purchasing an additional 233 shares during the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Solventum by 2.0% in the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,677 shares of the company’s stock valued at $904,000 after purchasing an additional 264 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Piper Sandler boosted their price target on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Mizuho assumed coverage on shares of Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. Finally, Morgan Stanley boosted their price target on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $68.29.

Solventum Stock Down 1.9 %

Solventum stock opened at $73.08 on Monday. The firm’s 50 day simple moving average is $71.14 and its 200-day simple moving average is $69.24. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.